HealthEquity, Inc. terminated Michael Fiore as Chief Commercial Officer without cause, effective October 5, 2026, and will redistribute his responsibilities among other members of its management team.
HQY · Healthequity, Inc. · Documents
$104.22
+0.76 (+0.73%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q2 2027 earnings call transcript
Market Cap
$8.56B
Shares
82.72M
Volume · Nov 16
234.01K
Avg daily vol (3M)
867.78K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Oct 9
Current report
8-K
Events of Oct 5
Director or officer change, or executive pay
Sep 30
Current report
8-K
Events of Sep 24
Director or officer change, or executive pay, Regulation FD disclosure
HealthEquity appointed Noémie Heuland, Moody’s Corporation’s CFO, to its board effective September 24, 2026, expanding it to eleven members; she will join the Audit and Risk and Cybersecurity and Technology Committees.
Aug 27
Aug 27
Aug 27
Quarterly report
10-Q
FY2027 Q2, ended Jul 31
Quarterly report for FY2027 Q2
AI summary on its way
Revenue $350.73M
▲ 7.6%
Net income $65.64M
▲ 9.7%
Diluted EPS $0.78
▲ 14.7%
Jun 26
May 28
May 28
May 28
Quarterly report
10-Q
FY2027 Q1, ended Apr 30
Quarterly report for FY2027 Q1
AI summary on its way
Revenue $354.64M
▲ 7.2%
Net income $69.42M
▲ 28.8%
Diluted EPS $0.82
▲ 34.4%
May 13
May 13
May 13
May 8
Current report
8-K
Events of May 5
Director or officer change, or executive pay
AI summary on its way
Apr 6
Mar 30
Current report
8-K
Events of Mar 26
Director or officer change, or executive pay, Regulation FD disclosure
AI summary on its way
Mar 17
Mar 17
Mar 17
Annual report
10-K
FY2026, ended Jan 31
Annual report for FY2026
AI summary on its way
Revenue $1.31B
▲ 9.5%
Net income $215.2M
▲ 122.5%
Diluted EPS $2.46
▲ 125.7%
Feb 17
Jan 12
2025
Dec 3
Earnings call
Q3 2026 earnings call
Dec 3
Current report
8-K
Financial results
Dec 3
Quarterly report
10-Q
FY2026 Q3, ended Oct 31
Quarterly report for FY2026 Q3
Revenue $322.16M
▲ 7.2%
Net income $51.69M
▲ 806.4%
Diluted EPS $0.59
▲ 883.3%
Sep 2
Earnings call
Q2 2026 earnings call
Sep 2
Current report
8-K
Financial results
Sep 2
Quarterly report
10-Q
FY2026 Q2, ended Jul 31
Quarterly report for FY2026 Q2
Revenue $325.84M
▲ 8.6%
Net income $59.85M
▲ 67.1%
Diluted EPS $0.68
▲ 70.0%
Jun 27
Current report
8-K
Events of Jun 26
Shareholder vote results, Regulation FD disclosure
Jun 3
Earnings call
Q1 2026 earnings call
Jun 3
Current report
8-K
Financial results
Jun 3
Quarterly report
10-Q
FY2026 Q1, ended Apr 30
Quarterly report for FY2026 Q1
Revenue $330.84M
▲ 15.0%
Net income $53.92M
▲ 87.1%
Diluted EPS $0.61
▲ 84.8%
May 13
Proxy statement
DEF 14A
Proxy statement
May 13
Annual report to holders
ARS
Annual report to holders
May 13
Proxy statement
DEFA14A
Proxy statement
Apr 28
Current report
8-K
Events of Apr 22
Director or officer change, or executive pay
Mar 18
Earnings call
Q4 2025 earnings call
Mar 18
Current report
8-K
Financial results
Mar 18
Annual report
10-K
FY2025, ended Jan 31
Annual report for FY2025
Revenue $1.2B
▲ 20.0%
Net income $96.7M
▲ 73.6%
Diluted EPS $1.09
▲ 70.3%
Feb 18
Current report
8-K
Financial results
Jan 13
Current report
8-K
Regulation FD disclosure
2024
Dec 9
Earnings call
Q3 2025 earnings call
Dec 9
Current report
8-K
Financial results
Dec 9
Quarterly report
10-Q
FY2025 Q3, ended Oct 31
Quarterly report for FY2025 Q3
Revenue $300.43M
▲ 20.5%
Net income $5.7M
▼ 61.1%
Diluted EPS $0.06
▼ 64.7%
Nov 29
Current report
8-K
Events of Nov 27
Entered into a material agreement
Nov 12
Current report
8-K
Events of Nov 11
Director or officer change, or executive pay, Regulation FD disclosure
Sep 6
Registration statement
S-3ASR
Registration statement
Sep 3
Earnings call
Q2 2025 earnings call
Sep 3
Current report
8-K
Financial results
Sep 3
Quarterly report
10-Q
FY2025 Q2, ended Jul 31
Quarterly report for FY2025 Q2
Revenue $299.93M
▲ 23.1%
Net income $35.82M
▲ 238.6%
Diluted EPS $0.40
▲ 233.3%
Aug 27
Current report
8-K
Events of Aug 23
Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation
Jul 2
Current report
8-K
Other events
Showing 1–50 of 176 documents
Key facts
CIK
1428336
CUSIP
42226A107
13F (30d)
418 filings
380 filers
Visit website
Investor relations